Based on 6 analysts giving stock ratings to Apyx Medical Corp in the past month.
In the current month, APYX has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. APYX average Analyst price target in the last month is 6.500.
Based on analysts' estimates, APYX EPS is projected to reach -0.093 in FY2026Q3, following reported EPS of -0.074 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.07, while Apyx Medical CorpAPYX's earnings per share (EPS) for the previous quarter was USD -0.05. EPS for the next quarter is expected at USD -0.09.